Black Rock Inc. Dia Medica Therapeutics Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 105,303 shares of DMAC stock, worth $662,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
105,303
Previous 103,370
1.87%
Holding current value
$662,355
Previous $286,000
8.39%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding DMAC
# of Institutions
49Shares Held
5.18MCall Options Held
8.2KPut Options Held
200-
Vanguard Group Inc Valley Forge, PA1.24MShares$7.81 Million0.0% of portfolio
-
First Manhattan CO New York, NY839KShares$5.28 Million0.01% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX515KShares$3.24 Million6.41% of portfolio
-
Bleichroeder LP New York, NY382KShares$2.4 Million0.63% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA375KShares$2.36 Million0.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $166M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...